Granules India announced that its wholly owned foreign subsidiary Granules Pharmaceuticals Inc located in Chantilly Virginia USA had undergone a Preapproval Inspection PAI by the US Food and Drug Administration USFDA from 24 to 28 January 2022 The audit is a PAI for two of its product applications filed from this facility The USFDA issued three minor observations during the audit conducted at the facility
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
